周四盘中，同位素技术公司ASP Isotopes Inc.（股票代码：ASPI）股价出现显著上涨，涨幅达5.51%，引发市场关注。
此次股价上涨主要受益于分析师的积极评级。加拿大投资银行集团重申了对ASP Isotopes的"买入"评级，并将目标价从8.50美元上调至11.00美元。这一利好消息提振了投资者信心，推动了股价的上涨。
ASP Isotopes Inc.是一家处于商业前期阶段的先进材料公司，专注于开发可用于多个行业的同位素生产技术。该公司利用过去20年在南非开发的技术来富集原子质量较低的元素或分子的同位素。
截至盘中交易，ASP Isotopes股价报8.15美元/股，成交量达94.97万股，换手率为1.27%，振幅4.70%。值得注意的是，在所有参与评级的机构中，100%的券商给予买入建议，显示出分析师对公司前景的看好。然而，投资者仍需谨慎，考虑到公司最近的财报显示净亏损为845万美元，每股亏损0.12美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.